Over at FiercePharm.com is a free report by Sermo on;
Which New Hepatitis C Drug do MDs Prefer?
Incivek (telaprevir) vs. Victrelis (boceprevir)
If you're curious you can Click Here and register to get the results.
Wednesday, August 10, 2011 Over 90% of physicians are aware the new Hep C drugs Incivek and Victrelis are available. A new free report from Sermo reveals insight into what physicians are prescribing patients, the key factors compelling them to select one drug over the other, and which drug they think will become the standard of care.
Physicians were asked to share their perspective on:
General awareness and use of these new treatments
"Real-life" efficacy of each drug with current patients
Which product will become the standard of care